Literature DB >> 18757367

Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processing.

Chrysoula Daskalogianni1, Sébastien Apcher, Marco M Candeias, Nadia Naski, Fabien Calvo, Robin Fåhraeus.   

Abstract

Partial degradation or regulated ubiquitin proteasome-dependent processing by the 26 S proteasome has been demonstrated, but the underlying molecular mechanisms and the prevalence of this phenomenon remain obscure. Here we show that the Gly-Ala repeat (GAr) sequence of EBNA1 affects processing of substrates via the ubiquitin-dependent degradation pathway in a substrate- and position-specific fashion. GAr-mediated increase in stability of proteins targeted for degradation via the 26 S proteasome was associated with a fraction of the substrates being partially processed and the release of the free GAr. The GAr did not cause a problem for the proteolytic activity of the proteasome, and its fusion to the N terminus of p53 resulted in an increase in the rate of degradation of the entire chimera. Interestingly the GAr had little effect on the stability of EBNA1 protein itself, and targeting EBNA1 for 26 S proteasome-dependent degradation led to its complete degradation. Taken together, our data suggest a model in which the GAr prevents degradation or promotes endoproteolytic processing of substrates targeted for the 26 S proteasome by interfering with the initiation step of substrate unfolding. These results will help to further understand the underlying mechanisms for partial proteasome-dependent degradation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757367      PMCID: PMC2662073          DOI: 10.1074/jbc.M803290200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.

Authors:  Stijn Heessen; Ainars Leonchiks; Natalia Issaeva; Anatoly Sharipo; Galina Selivanova; Maria G Masucci; Nico P Dantuma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.

Authors:  J Tellam; M Sherritt; S Thomson; R Tellam; D J Moss; S R Burrows; E Wiertz; R Khanna
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

3.  Degradation signals in ErbB-2 dictate proteasomal processing and immunogenicity and resist protection by cis glycine-alanine repeat.

Authors:  M P Piechocki; S A Pilon; C Kelly; W Z Wei
Journal:  Cell Immunol       Date:  2001-09-15       Impact factor: 4.868

Review 4.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

5.  Taking a bite: proteasomal protein processing.

Authors:  Michael Rape; Stefan Jentsch
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

Review 6.  Membrane-bound transcription factors: regulated release by RIP or RUP.

Authors:  T Hoppe; M Rape; S Jentsch
Journal:  Curr Opin Cell Biol       Date:  2001-06       Impact factor: 8.382

7.  Inhibition of ubiquitin-dependent proteolysis by a synthetic glycine-alanine repeat peptide that mimics an inhibitory viral sequence.

Authors:  Ainars Leonchiks; Vaya Stavropoulou; Anatoly Sharipo; Maria G Masucci
Journal:  FEBS Lett       Date:  2002-07-03       Impact factor: 4.124

Review 8.  Stabilization signals: a novel regulatory mechanism in the ubiquitin/proteasome system.

Authors:  Nico P Dantuma; Maria G Masucci
Journal:  FEBS Lett       Date:  2002-10-02       Impact factor: 4.124

9.  p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.

Authors:  Yili Yin; C W Stephen; M Gloria Luciani; Robin Fåhraeus
Journal:  Nat Cell Biol       Date:  2002-06       Impact factor: 28.824

Review 10.  Avoiding proteasomal processing: the case of EBNA1.

Authors:  N P Dantuma; A Sharipo; M G Masucci
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

View more
  28 in total

Review 1.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

Review 2.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

3.  mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1.

Authors:  Sebastien Apcher; Anastassia Komarova; Chrysoula Daskalogianni; Yili Yin; Laurence Malbert-Colas; Robin Fåhraeus
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

4.  Slippery substrates impair ATP-dependent protease function by slowing unfolding.

Authors:  Daniel A Kraut
Journal:  J Biol Chem       Date:  2013-10-22       Impact factor: 5.157

5.  Scherrer and Jost's symposium: the gene concept in 2008.

Authors:  Donald R Forsdyke
Journal:  Theory Biosci       Date:  2009-08-21       Impact factor: 1.919

6.  High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.

Authors:  Giuseppe Coppotelli; Nouman Mughal; Diego Marescotti; Maria G Masucci
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

7.  Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.

Authors:  Federica Destro; Fabio Sforza; Mariaconcetta Sicurella; Diego Marescotti; Eleonora Gallerani; Anna Baldisserotto; Mauro Marastoni; Riccardo Gavioli
Journal:  Immunology       Date:  2011-02-22       Impact factor: 7.397

Review 8.  Multitasking with ubiquitin through multivalent interactions.

Authors:  Fen Liu; Kylie J Walters
Journal:  Trends Biochem Sci       Date:  2010-02-22       Impact factor: 13.807

9.  Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.

Authors:  Xiaoping Sun; Elizabeth A Barlow; Shidong Ma; Stacy R Hagemeier; Sarah J Duellman; Richard R Burgess; Judy Tellam; Rajiv Khanna; Shannon C Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

Review 10.  Context-dependent resistance to proteolysis of intrinsically disordered proteins.

Authors:  Marcin J Suskiewicz; Joel L Sussman; Israel Silman; Yosef Shaul
Journal:  Protein Sci       Date:  2011-06-08       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.